---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-24-032624"
form_type: "8-K"
ticker: "ASTH"
cik: "0001083446"
company_name: "Astrana Health, Inc."
filed_at: "2024-03-11T23:59:59+00:00"
generated_at: "2026-06-04T23:40:41.208770+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Astrana Health issues FY2024 revenue $1.65-1.85B, Adj. EBITDA $165-185M

## Summary
- FY2023 rev $1.39B, Adj. EBITDA $146.6M, diluted EPS $1.29.
- FY2024 guidance: rev $1.65-1.85B, Adj. EBITDA $165-185M, EPS $1.28-1.52.
- Closed CFC acquisition Jan 31, 2024; $202M total (cash $152M, equity $20M, milestones $30M).
- 10,000+ providers, ~900k VBC members; 48% fewer hospital admits vs benchmark.
- Care Enablement segment long-term EBITDA margin target 20-30%.

## SEC filing metadata
- accession: 0001104659-24-032624
- form_type: 8-K
- ticker: ASTH
- cik: 0001083446
- company_name: Astrana Health, Inc.
- filed_at: 2024-03-11T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1083446/000110465924032624/0001104659-24-032624-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1083446/000110465924032624/tm247913d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-24-032624
- JSON: https://secwatch.observer/filing/0001104659-24-032624.json
- Plain text: https://secwatch.observer/filing/0001104659-24-032624.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.